American Oncology Network, Inc. (AONC) Q1 2024 Earnings Call Transcript

American Oncology Network, Inc. (NASDAQ:AONC) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET

Company Participants

David Gould – Chief Financial Officer
Todd Schonherz – Chief Executive Officer

Conference Call Participants

Operator

Good morning and welcome to the American Oncology Network’s First Quarter 2024 Earnings Conference Call. Today’s call is being recorded and we have allocated one hour for prepared remarks and Q&A.

At this time I’d like to turn the conference over to David Gould, Chief Financial Officer at AON. Thank you, you may begin.

David Gould

Good morning everyone and thank you for joining us to discuss American Oncology Network’s first quarter of 2024 results. Before we begin, we would like to remind you that this conference call may include forward-looking statements. These statements, which are subject to various risks, uncertainties, and assumptions could cause our actual results to differ materially from these statements.

These risks, uncertainties, and assumptions are detailed in yesterday’s press release as well as our filings with the SEC, which can be found on our website at investors.aoncology.com. We undertake no obligation to revise or update any forward-looking statements or information except as required by law.

During our call today, we will also reference certain non-GAAP financial information such as adjusted EBITDA, which is derived from the closest GAAP measure net income. We use this non-GAAP measures as we believe it supplements nearest GAAP measure and we believe it is useful for our investors.

This presentation of the non-GAAP financial information is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with GAAP. Reconciliation of GAAP to non-GAAP measures can be found in yesterday’s press release and in our SEC filings.

Joining me on the call today is our CEO, Todd Schonherz. Following our